Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AVITA Medical (RCEL) EBT Margin (2018 - 2025)

AVITA Medical's EBT Margin history spans 8 years, with the latest figure at 12.65% for Q4 2025.

  • For Q4 2025, EBT Margin fell 28543.0% year-over-year to 12.65%; the TTM value through Dec 2025 reached 33.35%, down 3333.0%, while the annual FY2025 figure was 67.83%, 6781.0% down from the prior year.
  • EBT Margin reached 12.65% in Q4 2025 per RCEL's latest filing, up from 77.95% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 272.78% in Q4 2024 to a low of 167.76% in Q1 2024.
  • Average EBT Margin over 5 years is 41.65%, with a median of 74.81% recorded in 2025.
  • Peak YoY movement for EBT Margin: soared 32294bps in 2023, then crashed -28543bps in 2025.
  • A 5-year view of EBT Margin shows it stood at 84.64% in 2021, then soared by 32bps to 57.79% in 2022, then soared by 559bps to 265.15% in 2023, then increased by 3bps to 272.78% in 2024, then crashed by -105bps to 12.65% in 2025.
  • Per Business Quant, the three most recent readings for RCEL's EBT Margin are 12.65% (Q4 2025), 77.95% (Q3 2025), and 54.41% (Q2 2025).